Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Poetic talent unmasked by treatment of Parkinson's disease

Identifieur interne : 004719 ( Main/Exploration ); précédent : 004718; suivant : 004720

Poetic talent unmasked by treatment of Parkinson's disease

Auteurs : Anette Schrag [Royaume-Uni] ; Michael Trimble [Royaume-Uni]

Source :

RBID : ISTEX:6B926782EB0AA7C9D6EF1ED8EC6906ECA2DEE4DC

Descripteurs français

English descriptors

Abstract

Parkinson's disease is typically characterised by loss of function and previous abilities, often accompanied by complications of treatment in later stages of the disease. We report on a patient who newly developed an artistic skill after starting treatment for Parkinson's disease. This case offers insight into the neurology of the artistic process as well as into the pathophysiology of psychiatric adverse reactions to the treatment of PD. © 2001 Movement Disorder Society.

Url:
DOI: 10.1002/mds.1239


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Poetic talent unmasked by treatment of Parkinson's disease</title>
<author>
<name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
</author>
<author>
<name sortKey="Trimble, Michael" sort="Trimble, Michael" uniqKey="Trimble M" first="Michael" last="Trimble">Michael Trimble</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6B926782EB0AA7C9D6EF1ED8EC6906ECA2DEE4DC</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1002/mds.1239</idno>
<idno type="url">https://api.istex.fr/document/6B926782EB0AA7C9D6EF1ED8EC6906ECA2DEE4DC/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001958</idno>
<idno type="wicri:Area/Istex/Curation">001958</idno>
<idno type="wicri:Area/Istex/Checkpoint">002F46</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Schrag A:poetic:talent:unmasked</idno>
<idno type="wicri:Area/Main/Merge">006C01</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:02-0176264</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002903</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000418</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002927</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Schrag A:poetic:talent:unmasked</idno>
<idno type="wicri:Area/Main/Merge">006E26</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:11748756</idno>
<idno type="wicri:Area/PubMed/Corpus">003C19</idno>
<idno type="wicri:Area/PubMed/Curation">003C19</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003C69</idno>
<idno type="wicri:Area/Ncbi/Merge">000632</idno>
<idno type="wicri:Area/Ncbi/Curation">000632</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000632</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Schrag A:poetic:talent:unmasked</idno>
<idno type="wicri:Area/Main/Merge">006971</idno>
<idno type="wicri:Area/Main/Curation">004719</idno>
<idno type="wicri:Area/Main/Exploration">004719</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Poetic talent unmasked by treatment of Parkinson's disease</title>
<author>
<name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Raymond Way Neuropsychiatry Research Group, Institute of Neurology, University College London, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Trimble, Michael" sort="Trimble, Michael" uniqKey="Trimble M" first="Michael" last="Trimble">Michael Trimble</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Raymond Way Neuropsychiatry Research Group, Institute of Neurology, University College London, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2001-11">2001-11</date>
<biblScope unit="vol">16</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1175">1175</biblScope>
<biblScope unit="page" to="1176">1176</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">6B926782EB0AA7C9D6EF1ED8EC6906ECA2DEE4DC</idno>
<idno type="DOI">10.1002/mds.1239</idno>
<idno type="ArticleID">MDS1239</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Agonist</term>
<term>Antiparkinson Agents (pharmacology)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Antiparkinson agent</term>
<term>Artist</term>
<term>Case study</term>
<term>Chemotherapy</term>
<term>Creativity</term>
<term>Dopamine Agonists (pharmacology)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Dopamine receptor</term>
<term>Ergot derivatives</term>
<term>Evolution</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa</term>
<term>Levodopa (pharmacology)</term>
<term>Libido (drug effects)</term>
<term>Lisuride</term>
<term>Lisuride (pharmacology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (psychology)</term>
<term>Parkinson disease</term>
<term>Poetry</term>
<term>Poetry as Topic</term>
<term>Serotonin Receptor Agonists (pharmacology)</term>
<term>Serotonin Receptor Agonists (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Dopamine Agonists</term>
<term>Levodopa</term>
<term>Lisuride</term>
<term>Serotonin Receptor Agonists</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Dopamine Agonists</term>
<term>Serotonin Receptor Agonists</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Libido</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Creativity</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Poetry as Topic</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Agoniste</term>
<term>Antiparkinsonien</term>
<term>Artiste</term>
<term>Chimiothérapie</term>
<term>Ergot dérivé</term>
<term>Etude cas</term>
<term>Evolution</term>
<term>Homme</term>
<term>Lisuride</term>
<term>Lévodopa</term>
<term>Parkinson maladie</term>
<term>Poésie</term>
<term>Récepteur dopaminergique</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Parkinson's disease is typically characterised by loss of function and previous abilities, often accompanied by complications of treatment in later stages of the disease. We report on a patient who newly developed an artistic skill after starting treatment for Parkinson's disease. This case offers insight into the neurology of the artistic process as well as into the pathophysiology of psychiatric adverse reactions to the treatment of PD. © 2001 Movement Disorder Society.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement>
<li>Londres</li>
</settlement>
</list>
<tree>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
</region>
<name sortKey="Trimble, Michael" sort="Trimble, Michael" uniqKey="Trimble M" first="Michael" last="Trimble">Michael Trimble</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004719 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004719 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:6B926782EB0AA7C9D6EF1ED8EC6906ECA2DEE4DC
   |texte=   Poetic talent unmasked by treatment of Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024